| 1731 |
LUCIFEZO |
FEZOLINETANT 45 MG |
TABLET |
BOTTLE |
Treatment of moderate to severe vasomotor symptoms due to menopause |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 1150/24 |
2024-07-30 |
2027-07-29 |
View |
| 1732 |
LUCIFIDA |
FIDAXOMICIN 200 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF CLOSTRIDIOIDES DIFFICILE INFECTION ALSO KNOWN AS C.DIFFICILE ASSOCIATED DIARRHEA IN ADULT AND PAEDIATRIC PATIENTS WITH A BODY WEIGHT OF AT LEAST 12.5 KG |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
04 L 1089/24 |
08-APR-2024 |
07-APR-2027 |
View |
| 1733 |
LUCIFILGO |
FILGOTINIB 100 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF MODERATE TO SEVERE ACTIVE RHEUAMTOID ARTHRITIS AND MODERRATELY TO SEVERE ACCTIVE ULCERATIVE COLITIS IN ADULT PATIENTS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
06 L 1112/24 |
21-JUN-2024 |
20 JUN 2027 |
View |
| 1734 |
LUCIFINE |
FINERENONE 10 MG |
FILM COATED TABLET |
BOTTLE |
TO REDUCE THE RISK OF SUSTAINED EGFR DECLINE, END STAGE KIDNEY DISEASE |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 0994/23 |
31-JUL-2023 |
30-JUL-2026 |
View |
| 1735 |
LUCIFUTIB |
FUTIBATINIB 4 MG |
TABLET |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH PREVIOUSLY TREATED, UNRESECTABLE, LOCALLY ADVANCED OR METASTATIC INTRAHEPATIC CHOLANGIOCARCINOMA HARBORING FIBROBLAST GROWTH FACTOR RECEPTOR 2 GENE FUSION OR OTHER REAARANGEMENTS |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1212/24 |
02-OCT-2024 |
01-OCT-2029 |
View |
| 1736 |
LUCIGEFI 250 MG |
GEFITINIB 250 MG |
TABLET |
BOTTLE |
FOR THE FIRST LINE TREATMENT OF PATIENTS WITH METASTATIC NON SMALL CELL LUNG CANCER WHOSE TUMORS HAVE EPIDERMAL GROWTH FACTOR RECEPTOR EXON 19 DELETIONS OR EXON 21 |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
09 L 1215/24 |
31-OCT-2024 |
30-OCT-2029 |
View |
| 1737 |
LUCIGIL |
GILTERITINIB 40 MG |
TABLET |
BOTTLE |
TREATMENT OF ACUTE MYELOID LEUKEMIA |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
07 L 0995/23 |
31-JUL-2023 |
30-JUL-2026 |
View |
| 1738 |
LUCILARO |
LAROTRECTINIB 100 MG |
CAPSULE |
BOTTLE |
FOR TREATMENT OF ADULT AND PAEDIATRIC PATIENTS WITH SOLID TUMORS. |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
05 L 0977/23 |
17-MAY-2023 |
16-MAY-2026 |
View |
| 1739 |
LUCILAZER |
LAZERTINIB 80 MG |
TABLET |
BOTTLE |
IN COMBINATION WITH AMIVANTAMAB FOR THE FISRT LINE TREATMENT OF ADULT PATIENTS WITH LOCALLY ADVANCED OR METASTATIC NON SMALL CELL LUNG CANCER WITH EPIDERMAL GROWTH FACTOR RECEPTOR EXON 19 DELETION OR EXON 21 L858R SUBSTITUTION MUTATION |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
03 L 1326/25 |
07-APR-2025 |
06-APR-2030 |
View |
| 1740 |
LUCILENA |
LENALIDOMIDE 10 MG |
CAPSULE |
BOTTLE |
FOR THE TREATMENT OF ADULT PATIENTS WITH MULTIPLE MYELOMA IN COMBINATION WITH DEXAMETHASONE, MULTIPLE MYELOM, AS MAINTENANCE FOLLOWING AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION |
NULL |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LUCIUS PHARMACEUTICALS(LAO) CO.,LTD |
LAOS |
CERTIFICATE RELEASED |
12 L 1284/24 |
23-JAN-2025 |
22-JAN-2030 |
View |
